职来职往

三明：借智创新老区攀高_我的网站

三少爷的剑

一 | AI摘要三明探索“京沪研发+三明制造”协同创新路径，依托对口合作承接资源外溢，优化营商与服务环境。上半年技术合同登记金额增超4倍，推动科技与产业深度融合。 RAVENA, N.Y. -- New York officials launched legal recreational marijuana sales by promising many of the first retail licenses to people with past drug convictions, hoping to give people harmed by the war on drugs a chance to succeed before competitors crowded in.But more than nine months after sales started, only about two dozen state-sanctioned dispensaries have opened their doors. Legal challenges over the state's permitting process have left more than 400 provisional licensees in limbo. Marijuana farmers are reeling because there are too few stores to sell their harvest.State regulators are now expanding the market amid those troubles. They recently opened up a 60-day general application window to grow, process, distribute or sell marijuana, expecting to issue more than 1,000 new licenses. New rules also will allow companies licensed to grow and sell medical marijuana in New York to get into the recreational market.The moves are expected to boost the number of legal dispensaries in a market now dominated by black-market sellers who simply opened retail stores without a license. But the prospect of competing with the medical providers worries some farmers and retailers who fear being squeezed by deeper-pocketed companies before they had a chance to establish themselves.“My concern is that they have all the money to bleed us out,” said Coss Marte, whose opening of CONBUD dispensary in Manhattan was pushed back by a lawsuit against state regulators. “They’re vertically integrated. So now what they could do is ... grow their own product at the cheapest price and basically outbid all the farmers, all our products and all our pricing.”Critics blame New York’s slow retail growth partly on bureaucratic issues, like delays in setting up a $200 million “social equity” fund to help applicants open shops. The rollout also was hobbled by lawsuits on behalf of people and businesses excluded from the first wave of retail licenses. Marte's shop was among those temporarily blocked by a judge from opening after a group sued on behalf of disabled veterans, saying they were wrongly excluded from applying for a license. Marte, who has a past drug arrest, was paying rent on a store he could not open.A judge recently ruled that Marte's store and several others could open. But the fate of many other provisional license holders, like Carson Grant of New York City, was unclear. After months of delays in opening his store in Queens, he was debating whether to reapply for a license again in this general round.“It's very difficult emotionally,” he said.Reginald Fluellen, senior consultant with the Cannabis Social Equity Coalition, blamed the state for a botched rollout.“They’ve failed miserably in providing the justice-involved individuals the kind of head start, the kind of foothold, in the market that they promised," Fluellen said.Under new regulations, medical marijuana providers could begin retail recreational sales at one of their existing dispensaries as early as Dec. 29. They could begin selling recreational pot at two more dispensaries six months after that. The entry price for those companies is steep: a $20 million licensing fee, with $5 million due upfront. But multiple companies are expected to jump in.“We expect New York to be the hub, or one of the hubs, for legal cannabis on the East Coast,” said Curaleaf CEO Matt Darin. “And so we’re very bullish and we’ve invested a lot of capital and time to be able to maximize the opportunity.”Curaleaf, which operates in multiple states, has already invested $50 million in New York, most of it on a recently expanded indoor growing facility south of Albany that now serves the medical market. Rows of plants there mature in intensely lit rooms where humidity, temperature and nutrition are tightly controlled — a scene in stark contrast to the fields and greenhouses that have defined New York’s adult-use market since growing started last year.Curaleaf will be able to double the size of the facility’s canopy to 64,000 square feet, or about 1.5 acres (0.61 hectares), if the market dictates, said Joe Holland, an executive vice president.To guard against retail monopolies, the medical providers will be limited to three retail outlets. And in a nod to farmers, their shops will initially have to devote half their shelf space to products grown and processed by independent businesses.Still, critics say the state should have allowed more time for economically and socially diverse entrepreneurs to succeed before letting in larger competitors.Joseph Calderone of Grateful Valley Farm, near the Pennsylvania border, compared it to little hardware stores competing against big box stores. Large indoor facilities, he said, can produce multiple crops a year. Meanwhile, farms having trouble selling their crops are “teetering on the edge of failure,” he said.“We were given a fair chance to grow. We were asked to do that," he said. "We kept our promise. The state did not keep their promise.” Office of Cannabis Management executive director Chris Alexander said the new regulations maintain New York’s commitment to social and economic equity, while keeping the market more competitive than in other states. That includes giving priority consideration for social and equity applicants in the current round.While acknowledging there was some “frustration” in getting retail stores open, Alexander said the state has shown a market supplied by small farmers can work. "We've got some of the top-performing dispensaries in the country right here in New York," Alexander saidAnd there’s still room to grow. Regulators have estimated New York will eventually require at least 2,000 dispensaries to meet demand. “I think there’s enough business to go around,” said Christian Chavez, CEO of Statis Cannabis Co. He said sales have been good since they opened their dispensary in the Bronx in July. “I think it’ll be quite some time until this market gets saturated in New York.”。

二 | 沙溪河畔，创新潮涌。走进三明中关村科技园的津准（三明）医学技术有限公司展厅，摆在醒目位置的是一台外观类似共享充电宝机柜的设备，机柜上插着一个个卡片大小的白色小盒子。津准医学执行董事沈平抽出一个小白盒，把电极片贴在记者手臂上，按下盒子上的开关。一瞬间，电极片覆盖下的手部肌肉不受控制地抽动起来，一缩一放，像是被什么力量轻轻地“拽”着。这就是津准医学的主营产品——数字化无线中频治疗仪。 “中频”的电流频率在1000到10万赫兹之间。

三 | 这个频段的特点在于，它能穿透皮肤表层、刺激深层肌肉神经，却不会激活痛觉神经。津准医学做的就是把这种原本只在大型医院里见到的康复理疗设备，做成巴掌大的、可以随身携带的小仪器。

四 | “这款电疗仪内置了康复领域专家的治疗方案，现在我们可以说，从北京的中日友好医院，到连江县马鼻镇的卫生所，用的方案都是一模一样的。

五 | ”沈平底气十足。一台三明生产的小设备，覆盖全国300多家医院。“四川华西、上海华山、上海仁济、湖北同济、湖南湘雅，这些顶级医院都在用。”沈平介绍，去年这款产品在全国三级医院中频治疗仪市场拿下销售额亚军、平均单价冠军，全年服务患者超过115万人次。其实，三明并不是这家公司的起点。

六 | 津准医学的母公司津准力行在上海，研发团队也在上海。2021年底，公司决定设立子公司布局生产制造环节，选址团队跑了好几个地方，最终被三明的营商环境打动。 “你看我这栋小楼，一年房租还不到6万元。”更让沈平安心的是三明中关村科技园的服务效率。二类医疗器械的产品注册证，行业平均审批周期是两年。

七 | 2022年4月，津准医学向福建省药监局递交申报材料，在园区全程协助下，同年8月就拿下了注册证。“这些流程我们基本不需要操心，园区有专人帮我们推进。” 还有不少细节让沈平觉得暖心。“园区领导的办公室，企业家都是推门即进。每个员工每月300元的伙食补贴、拎包入住的单身公寓，让从上海派过来的团队成员能安心扎下来。” 5年时间，这家“上海研发、三明制造”的企业，已经手握35项知识产权，其中已授权发明专利5项。2024年，企业生产的产品进入福建省第二类创新医疗器械特别审查程序。“我们没有理由不选择三明。

八 | ”沈平说。 “京沪研发+三明制造”，这正是三明探索的协同创新路径。三明市科技局副局长陈东胜告诉记者，三明不走“给钱”的传统招商老路，而是依托沪明对口合作、京明科技合作等平台，主动承接北京、上海的创新资源外溢，把发达地区的“大脑”和山区的“手脚”连在一起。在三明中关村科技园，这样的故事不只一个。索富泵业是一家专注于微型磁力齿轮泵的国家高新技术企业，依托沪明合作平台，索富泵业与复旦大学在机械流体力学和材料学领域已合作两年。2021年入驻三明中关村科技园时，企业年营收1000余万元，2025年已攀升至4300万元。“全国各大顶尖高校实验室都采购我们的产品，就连福建舰上也有。”索富泵业厂长陈其斌说。 “京沪研发+三明制造”也可以是双向奔赴。福建东南航空科技有限公司是2024年5月成立的无人机企业，最终落子三明，看中的是这里“真刀真枪”的应用场景——11个县（市、区）山林河湖密布，在地灾应急、森林防火、林业巡检等方面有着丰富的刚需。公司科技发展中心主任林奎介绍，借助京明合作的中关村科技园平台，东南航空与北京相关科研院所达成战略合作，2026年自研信号中继设备项目成功落地。截至目前，三明已常态化征集73个创新应用场景需求并形成清单，在北京召开的京闽（三明）科技合作发布会上推介了首批20个应用场景，“京沪研发+三明制造”这条路正一步一步走实。